{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:38:25Z","timestamp":1794325105709,"version":"4.9.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:p>Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic features underlying this phenomenon by analyzing 93 patients: 29 developing HBV reactivation and 64 consecutive patients with chronic HBV infection (as control). HBsAg genetic diversity was analyzed by population\u2010based and ultradeep sequencing (UDS). Before HBV reactivation, 51.7% of patients were isolated hepatitis B core antibody (anti\u2010HBc) positive, 31.0% inactive carriers, 6.9% anti\u2010HBc\/anti\u2010HBs (hepatitis B surface antibody) positive, 6.9% isolated anti\u2010HBs positive, and 3.4% had an overt HBV infection. Of HBV\u2010reactivated patients, 51.7% were treated with rituximab, 34.5% with different chemotherapeutics, and 13.8% with corticosteroids only for inflammatory diseases. In total, 75.9% of HBV\u2010reactivated patients (vs. 3.1% of control patients; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001) carried HBsAg mutations localized in immune\u2010active HBsAg regions. Of the 13 HBsAg mutations found in these patients, 8 of 13 (M103I\u2010L109I\u2010T118K\u2010P120A\u2010Y134H\u2010S143L\u2010D144E\u2010S171F) reside in a major hydrophilic loop (target of neutralizing antibodies [Abs]); some of them are already known to hamper HBsAg recognition by humoral response. The remaining five (C48G\u2010V96A\u2010L175S\u2010G185E\u2010V190A) are localized in class I\/II\u2013restricted T\u2010cell epitopes, suggesting a role in HBV escape from T\u2010cell\u2010mediated responses. By UDS, these mutations occurred in HBV\u2010reactivated patients with a median intrapatient prevalence of 73.3% (range, 27.6%\u2010100%) supporting their fixation in the viral population as a predominant species. In control patients carrying such mutations, their median intrapatient prevalence was 4.6% (range, 2.5%\u201011.3%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). Finally, additional N\u2010linked glycosylation (NLG) sites within the major hydrophilic loop were found in 24.1% of HBV\u2010reactivated patients (vs. 0% of chronic patients; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001); 5 of 7 patients carrying these sites remained HBsAg negative despite HBV reactivation. NLG can mask immunogenic epitopes, abrogating HBsAg recognition by Abs. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: HBV reactivation occurs in a wide variety of clinical settings requiring immune\u2010suppressive therapy, and correlates with HBsAg mutations endowed with enhanced capability to evade immune response. This highlights the need for careful patient monitoring in all immunosuppressive settings at reactivation risk and of establishing a prompt therapy to prevent HBV\u2010related clinical complications. (H<jats:sc>epatology<\/jats:sc> 2015;61:823\u2013833)<\/jats:p>","DOI":"10.1002\/hep.27604","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T17:56:39Z","timestamp":1416592599000},"page":"823-833","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":112,"title":["Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression"],"prefix":"10.1097","volume":"61","author":[{"given":"Romina","family":"Salpini","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Colagrossi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Bellocchi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Surdo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Becker","sequence":"additional","affiliation":[{"name":"Institute of Virology,University of Cologne,Cologne,Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alteri","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Aragri","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ricciardi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit,Tor Vergata University Hospital,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Armenia","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Pollicita","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Di Santo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Carioti","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Louzoun","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Gonda Brain Research Center,Bar\u2010Ilan University,Ramat Gan,Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Maria","family":"Mastroianni","sequence":"additional","affiliation":[{"name":"Sapienza University,Polo Pontino,Latina,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Lichtner","sequence":"additional","affiliation":[{"name":"Sapienza University,Polo Pontino,Latina,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Paoloni","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit,\u201cS.S. Filippo e Nicola\u201d Hospital,Avezzano,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Esposito","sequence":"additional","affiliation":[{"name":"Hematology Unit,San Gennaro Hospital of Naples,Naples,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"D'Amore","sequence":"additional","affiliation":[{"name":"Internal Medicine and Hepatology Unit,Second University of Naples,Naples,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Marrone","sequence":"additional","affiliation":[{"name":"Internal Medicine and Hepatology Unit,Second University of Naples,Naples,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Marignani","sequence":"additional","affiliation":[{"name":"S. Andrea\u201d Hospital,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Sarrecchia","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit,Tor Vergata University Hospital,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit,Tor Vergata University Hospital,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit,Tor Vergata University Hospital,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Angelico","sequence":"additional","affiliation":[{"name":"Hepatology Unit,Tor Vergata University Hospital,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Verheyen","sequence":"additional","affiliation":[{"name":"Institute of Virology,University Hospital Essen, University Duisburg-Essen,Essen,Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo\u2010Federico","family":"Perno","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Svicher","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Surgery,University of Rome Tor Vergata,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"issue":"5 Suppl","key":"hep27604-bib-0001-20241017","first-page":"S156","article-title":"Reactivation of hepatitis B","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep27604-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrgastro.2013.216","article-title":"Management of patients with hepatitis B who require immunosuppressive therapy","volume":"11","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep27604-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy\u2010induced hepatitis B reactivation in lymphoma patients with resolved HBV\u2010infection: a prospective study","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep27604-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"465","DOI":"10.6004\/jnccn.2011.0045","article-title":"Why, when, and how to prevent hepatitis B virus reactivation in cancer patients undergoing chemotherapy","volume":"9","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"key":"hep27604-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy","volume":"148","year":"2008","journal-title":"Ann Intern Med"},{"key":"hep27604-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hep.22106","article-title":"A revisit of prophylactic lamivudine for chemotherapy\u2010associated hepatitis B reactivation in non\u2010Hodgkin's lymphoma: a randomized trial","volume":"47","year":"2008","journal-title":"Hepatology"},{"key":"hep27604-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2893.2007.00902.x","article-title":"Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta\u2010analysis","volume":"15","year":"2008","journal-title":"J Viral Hepat"},{"key":"hep27604-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4254\/wjh.v5.i11.612","article-title":"Hepatitis B virus reactivation with rituximab\u2010containing regimen","volume":"5","year":"2013","journal-title":"World J Hepatol"},{"key":"hep27604-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/infdis\/jis268","article-title":"Probable corticosteroid\u2010induced reactivation of latent hepatitis B virus infection in an HIV\u2010positive patient involving immune\u2010escape","volume":"205","year":"2012","journal-title":"J Infect Dis"},{"key":"hep27604-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jinf.2011.11.021","article-title":"Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti\u2010HBs\u2010positive and anti\u2010HBc\u2010negative patient treated with rituximab\u2010containing therapy","volume":"65","year":"2012","journal-title":"J Infect"},{"key":"hep27604-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jmv.23721","article-title":"Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count","volume":"86","year":"2014","journal-title":"J Med Virol"},{"key":"hep27604-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcv.2013.06.020","article-title":"HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient","volume":"58","year":"2013","journal-title":"J Clin Virol"},{"key":"hep27604-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2893.2009.01239.x","article-title":"Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg\u2010negative and anti\u2010HBc antibodies\u2010positive patients undergoing chemotherapy and\/or autologous stem cell transplantation for cancer","volume":"17","year":"2010","journal-title":"J Viral Hepat"},{"key":"hep27604-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3851\/IMP1633","article-title":"Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV\u2010reactivation following a rituximab\u2010based regimen","volume":"15","year":"2010","journal-title":"Antivir Ther"},{"key":"hep27604-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jmv.23567","article-title":"Snapshot on drug\u2010resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice","volume":"85","year":"2013","journal-title":"J Med Virol"},{"key":"hep27604-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350801300218","article-title":"A systematic review of T\u2010cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics","volume":"13","year":"2008","journal-title":"Antivir Ther"},{"key":"hep27604-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.1840160104","article-title":"Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells","volume":"16","year":"1992","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"hep27604-bib-0018-20241017","first-page":"11","article-title":"The clinical significance of surface antigen variants of hepatitis B virus","volume":"4","year":"1997","journal-title":"J Viral Hepat"},{"key":"hep27604-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.510270138","article-title":"Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high\u2010dose hepatitis B immune globulin after liver transplantation","volume":"27","year":"1998","journal-title":"Hepatology"},{"key":"hep27604-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/JVI.06353-11","article-title":"Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance","volume":"86","year":"2012","journal-title":"J Virol"},{"key":"hep27604-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/35085569","article-title":"Evolution of digital organisms at high mutation rates leads to survival of the flattest","volume":"412","year":"2001","journal-title":"Nature"},{"key":"hep27604-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2013.11.004","article-title":"N\u2010glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune\u2010escape","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"hep27604-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV\u2010specific T cells after long\u2010term effective therapy with nucleos(t)ide analogues","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"hep27604-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1200\/JCO.2012.48.5938","article-title":"Randomized controlled trial of entecavir prophylaxis for rituximab\u2010associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B","volume":"31","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27604","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.27604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.27604","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201503000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:41:03Z","timestamp":1729212063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201503000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27604","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]},"assertion":[{"value":"2014-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}